Cargando…
Multigene signatures for early breast cancer in clinical practice: A report of the Lombardy genomic assays for breast cancer working group
The increasing understanding of breast cancer biology has provided the basis for the development of multigene signatures aimed to improve the capability of clinicians to assess patients’ prognostication and risk stratification. Incorporating these tools in clinical practice has profoundly impacted o...
Autores principales: | Licata, Luca, Cosentini, Deborah, De Sanctis, Rita, Iorfida, Monica, Caremoli, Elena Rota, Vingiani, Andrea, Simoncini, Edda Lucia, Pruneri, Giancarlo, Munzone, Elisabetta, Bianchini, Giampaolo, Zambelli, Alberto, Tondini, Carlo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10025563/ https://www.ncbi.nlm.nih.gov/pubmed/36950554 http://dx.doi.org/10.3389/fonc.2023.1081885 |
Ejemplares similares
-
Prospective observational study on the impact of the 21-gene assay on treatment decisions and resources optimization in breast cancer patients in Lombardy: The BONDX study
por: Zambelli, Alberto, et al.
Publicado: (2020) -
Multigene tests for breast cancer: the physician’s perspective
por: Cognetti, Francesco, et al.
Publicado: (2021) -
Can multigene assays widen their clinical usefulness in early breast cancer treatment choice during the current COVID-19 outbreak in Italy?
por: Zambelli, Alberto, et al.
Publicado: (2020) -
Fulvestrant in Combination with CDK4/6 Inhibitors for HER2- Metastatic Breast Cancers: Current Perspectives
por: Iorfida, Monica, et al.
Publicado: (2020) -
Immunotherapy for HER2-Positive Breast Cancer: Clinical Evidence and Future Perspectives
por: Agostinetto, Elisa, et al.
Publicado: (2022)